# Registry First Wave Pilot A Creatinine Source Transition S2 Founder Approval 2026-08-24 v0.1

Status: Founder Approved for Version Control / Creatinine Source-Verified / Human Review, Active, Runtime and Retrieval Not Authorized

Founder: 蓝耀栋

Approval date: 2026-08-24

## 1. Purpose

This closeout records final Founder approval of the exact Creatinine Source Transition S2 artifacts for controlled version control. It binds approval to the exact final record SHA, exact nine-leaf diff, seven-source reverification, execution authorization, and Founder Review Packet. It does not authorize any lifecycle state above `source_verified` or any product/runtime use.

## 2. Repository Baseline

- Repository: `/Users/lanyaodong/Documents/congtie-api`
- Branch: `main`
- Initial HEAD: `a99b5312403d29c20383427cf746d0f26274987c`
- Initial origin/main: `a99b5312403d29c20383427cf746d0f26274987c`
- Initial staging: empty
- Approval date: `2026-08-24`

The branch, local and remote anchors, staging, task date, and all protected SHA gates passed before this approval closeout was created.

## 3. Exact C33, C36, and C37 Lineage

| Artifact | SHA-256 |
| --- | --- |
| C33 Source-Verified Transition Plan | `dd627b31e887553b85179da78f47a504ef7da5df8113b6154bbcee4ec5f70121` |
| C33 Transition Plan Founder Approval | `d3d90474ef17233bd8dbe0b7cc39409db061c1b0ee30a45a0e088fe9dac2f0c8` |
| C36 Creatinine Source-Addition Review Packet | `671654fc947a7c39bd915f44d12a049eda6697bfe098fc18b904afe39a987c44` |
| C37 Creatinine Source-Addition Founder Approval | `d34921843a9f8a1efcc65e941d3707ab838fdb930b471365bf8062d80755629b` |

This lineage establishes the independent NIDDK conversion-source prerequisite and the separately gated S2 lifecycle transition.

## 4. Exact C38 Execution Authorization

Path:

`agent/knowledge_seed_v0/registry_first_wave_pilot_a_creatinine_source_transition_s2_execution_authorization_2026_08_24.v0.1.md`

SHA-256:

`309abe87dca5913d8454b80bbeee192e83a662145a18614d889486b4d4b07369`

The document retains its reviewed `Final Version-Control Approval Pending` wording. This closeout is the authoritative final version-control approval.

## 5. Exact C38 Review Packet

Path:

`agent/knowledge_seed_v0/registry_first_wave_pilot_a_creatinine_source_transition_s2_review_packet_2026_08_24.v0.1.md`

SHA-256:

`ef6ae9929b94dd2ab57afb6b8d309bb903471152efa0598157f4cff7c29aaa72`

The packet retains its reviewed Draft/Founder-pending status and three Pending decision rows to preserve the exact reviewed bytes. This closeout records the final decisions.

## 6. Creatinine SHA Before

The committed C37 baseline was:

~~~text
Path: agent/biomarker_measurement_registry/records/BM-000023.creatinine.json
SHA-256: c8fd286a46334e2f9a4856503de37ff5d8f5dcdfc7128f8e5a7308ae75ae0fa6
~~~

## 7. Creatinine SHA After

Founder approves this exact final record:

~~~text
Path: agent/biomarker_measurement_registry/records/BM-000023.creatinine.json
SHA-256: 396661e7b187beaab9717b042a991dc185a62857f3f1b01a3aa1b4d9d3b51e01
~~~

No further record edit is authorized in this task.

## 8. Seven-Source Reverification

All seven current source targets were reopened and reviewed on `2026-08-24` during C38. Their identities, recorded roles, support boundaries, limitations, identifiers, and material withdrawal/retraction/deprecation status passed review. Before final commit, the same seven sources were reconfirmed without changing record dates or source objects.

## 9. Exact Source Matrix Result

| Source key | Role | Identity/scope stable | Material change before commit |
| --- | --- | --- | --- |
| `src-loinc-creat-mass` | `other_reviewed_role` | PASS: active mass-concentration terminology; no method claim | none |
| `src-loinc-creat-molar` | `other_reviewed_role` | PASS: active molar-concentration terminology; no method claim | none |
| `src-nist-creat` | `measurement_method` | PASS: reference measurement and IDMS traceability; not every-assay equivalence | none |
| `src-creat-method-2020` | `validation_evidence` | PASS: method comparability and interference scope; no universal continuity | none |
| `src-wst4045` | `reference_interval_source` | PASS: China adult serum reference/method context; not a universal interval | none |
| `src-ucum` | `other_reviewed_role` | PASS: unit syntax authority only | none |
| `src-niddk-creatinine-conversion` | `other_reviewed_role` | PASS: standardized SCr context and factor 88.4; not assay equivalence or diagnosis | none |

All seven source keys remain unique and `content_verified`. No source title, organization, role, `supports`, `does_not_support`, URL, DOI, PMID, note, or verification status changed.

## 10. Exact Concept Lifecycle Change

~~~text
RegistryConcept.lifecycle_status:
proposed -> source_verified
~~~

This transition confirms source verification only.

## 11. Exact Profile Lifecycle Change

~~~text
creatinine.serum_or_plasma.enzymatic.profile_status:
proposed -> source_verified
~~~

The Profile boundary, method, specimen, units, mappings, comparability, limitations, and permissions remain unchanged.

## 12. Exact Six Source-Date Changes

Only `access_date` changed from `2026-08-22` to `2026-08-24` for:

1. `src-loinc-creat-mass`;
2. `src-loinc-creat-molar`;
3. `src-nist-creat`;
4. `src-creat-method-2020`;
5. `src-wst4045`; and
6. `src-ucum`.

No other field in those SourceReference objects changed.

## 13. Exact NIDDK-Date Non-Change

`src-niddk-creatinine-conversion.access_date` was already `2026-08-24` in the committed C37 baseline and remains unchanged. The full NIDDK SourceReference object is byte-stable across S2.

## 14. Exact Governance-Date Non-Change

The following values were already `2026-08-24` and remain unchanged:

~~~text
governance_metadata.last_modified_date
governance_metadata.last_source_check_date
~~~

`created_date`, `reviewed_by`, and `reviewed_date` also remain unchanged.

## 15. Exact Status-Note Change

The approved final note is:

> Source verification completed for the canonical Creatinine definition and creatinine.serum_or_plasma.enzymatic Profile after exact unit-conversion authority was added. RegistryConcept and Profile are source_verified only; no assay equivalence, human review, active status, publication, runtime, retrieval, clinical claim, threshold or action authorization.

## 16. Exact Nine-Leaf Diff

~~~text
Changed existing scalar leaves = 9
Authorized leaves = 9
Unauthorized leaves = 0

Added keys = 0
Removed keys = 0
Added source objects = 0
Removed source objects = 0
Added Profiles = 0
Removed Profiles = 0
Array reordering = 0
~~~

The approved leaves are concept lifecycle, enzymatic Profile status, six source access dates, and the governance status note.

## 17. Schema and Validator Results

~~~text
JSON syntax = PASS
Draft 2020-12 Schema = PASS
Permanent Validator = PASS
Validator exit = 0
Warnings = 0
Errors = 0
Record checks = 25/25 PASS
~~~

Validation used Python `3.9.6` and `jsonschema[format]==4.25.1`.

## 18. Candidate Ledger Result

Candidate Ledger lineage resolved `candidate_key: creatinine` to namespace `BM` and First Wave membership. The Candidate Ledger SHA remains `b97f4b0e0aeaa4fae6e728c561e88019d3c9e0b34ce353c1cc2b27f5cd09bbe5` and no Candidate Ledger field was changed.

## 19. Cross-Registry Result

~~~text
Cross-Registry checks = 25/25 PASS
Registry records = 4
Source-verified concepts = 3
Source-verified Profiles = 3
Heart Rate concept and both Profiles = proposed
Human-reviewed lifecycle records = 0
Active/runtime/retrieval/published records = 0
User observations = 0
~~~

## 20. Version Decision

`version: v0.1` is approved and remains unchanged. S2 is a lifecycle/source-check metadata transition; it does not revise the stable Creatinine construct or Profile content.

## 21. Founder Decisions

~~~text
Decision 1: Final Creatinine RegistryConcept source_verified = Approved
Decision 2: Final enzymatic Profile source_verified = Approved
Decision 3: Exact nine-leaf diff = Approved
Decision 4: Seven-source reverification = Approved
Decision 5: version v0.1 = Approved
Decision 6: controlled three-commit push = Approved

Founder decisions approved = 6/6
Founder pending decisions = 0
~~~

Founder further confirms that Registry lifecycle `human_reviewed` and `active` remain unauthorized and Heart Rate S3 remains unauthorized.

## 22. Human-Review Lifecycle Boundary

Founder approves the exact SHA-identified Creatinine Registry record for version control at `lifecycle_status: source_verified`, together with its single `creatinine.serum_or_plasma.enzymatic` Profile at `profile_status: source_verified`. The approval binds to the exact nine-leaf S2 diff and seven-source reverification. It confirms source verification only and does not establish Registry lifecycle `human_reviewed` or `active`, or authorize publication, runtime, retrieval, database, API, Observation processing, user-health storage, diagnosis, treatment, personal targets or automatic action.

The record continues to contain:

~~~text
reviewed_by = []
reviewed_date = null
~~~

## 23. Explicit Non-Authorizations

This approval does not authorize:

- Heart Rate S3;
- `human_reviewed` or `active` lifecycle status;
- source, Profile, method, specimen, unit, formula, mapping, comparability, limitation, permission, or numeric-ID changes;
- claims, thresholds, ReferenceContexts, system relations, lifecycle relations, or device mappings;
- runtime, retrieval, publication, database, API, loader, index, Observation processing, Service Panel, or user-health storage;
- diagnosis, treatment, personal targets, or automatic action.

## 24. Git Commit Plan

The approved history consists of three separate commits followed by one non-force push to `origin/main`:

1. `docs: authorize Creatinine source transition S2` - exact C38 Execution Authorization only;
2. `feat: source-verify Creatinine Registry record` - exact final Creatinine record only;
3. `docs: approve Creatinine source transition S2` - exact C38 Review Packet and this closeout only.

Each staged manifest must match its allowlist exactly. No amend, squash, rebase, force push, or unrelated staging is authorized.

## 25. Next Gate

After a successful controlled push, the only recommended next step is:

`Step5-C40: Permanent Validator Mixed-Profile Lifecycle Hardening - Heart Rate S3 Prerequisite`

C40 may harden the Validator and self-tests only. It must not modify the Heart Rate record or execute S3 automatically.
